A detailed history of Horizon Investments, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Horizon Investments, LLC holds 81,331 shares of PFE stock, worth $2.02 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
81,331
Previous 81,205 0.16%
Holding current value
$2.02 Million
Previous $2.27 Million 3.57%
% of portfolio
0.05%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $3,490 - $3,955
126 Added 0.16%
81,331 $2.35 Million
Q2 2024

Aug 09, 2024

BUY
$25.26 - $29.6 $26,447 - $30,991
1,047 Added 1.31%
81,205 $2.27 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $1.31 Million - $1.5 Million
-50,463 Reduced 38.63%
80,158 $2.22 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $510,972 - $663,696
-19,555 Reduced 13.02%
130,621 $3.76 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $104,645 - $122,320
3,261 Added 2.22%
150,176 $4.98 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $141,951 - $164,234
-3,930 Reduced 2.61%
146,915 $5.39 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $2.36 Million - $3.07 Million
-59,933 Reduced 28.43%
150,845 $6.15 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $3,214 - $4,196
-77 Reduced 0.04%
210,778 $10.7 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $731,886 - $893,449
16,725 Added 8.62%
210,855 $9.15 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $577,669 - $684,935
-12,415 Reduced 6.01%
194,130 $10.1 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $869,067 - $1.08 Million
18,996 Added 10.13%
206,545 $10.6 Million
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $660,624 - $979,265
15,988 Added 9.32%
187,549 $11 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $2.41 Million - $3.1 Million
61,399 Added 55.74%
171,561 $7.32 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $2.34 Million - $2.65 Million
65,225 Added 145.15%
110,162 $4.28 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $1.5 Million - $1.7 Million
44,937 New
44,937 $1.63 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $1.9 Million - $2.41 Million
-56,660 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $862,330 - $1.01 Million
-27,160 Reduced 32.4%
56,660 $2.06 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $2.14 Million - $2.6 Million
-71,119 Reduced 45.9%
83,820 $2.71 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $519,300 - $741,967
-19,212 Reduced 11.03%
154,939 $5.01 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $4.82 Million - $5.47 Million
146,310 Added 525.52%
174,151 $6.82 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $88,242 - $114,425
2,716 Added 10.81%
27,841 $991,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $2.22 Million - $2.49 Million
-60,025 Reduced 70.49%
25,125 $1.09 Million
Q1 2019

May 16, 2019

BUY
$37.5 - $41.2 $685,125 - $752,724
18,270 Added 27.32%
85,150 $3.59 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $524,769 - $598,294
13,641 Added 25.62%
66,880 $2.92 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $169,351 - $205,412
4,913 Added 10.17%
53,239 $2.33 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $825,390 - $879,949
-25,027 Reduced 34.12%
48,326 $1.74 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $487,871 - $565,998
15,289 Added 26.33%
73,353 $2.6 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $517,858 - $549,465
15,570 Added 36.64%
58,064 $1.92 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $895,592 - $950,253
-26,927 Reduced 38.79%
42,494 $1.4 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $2.15 Million - $2.37 Million
69,421
69,421 $2.29 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $139B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Horizon Investments, LLC Portfolio

Follow Horizon Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investments, LLC with notifications on news.